Year: 2024

BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)

FendX Advancing REPELWRAP(TM) Film with Dunmore by Conducting an Additional Pilot Manufacturing Run on Dunmore’s Commercial Manufacturing Line and Provides Corporate Update

Oakville, Ontario--(Newsfile Corp. - April 23, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or...

Alliance Spine and Pain Centers Implement Behavioral Health Screening With Mental Health Technologies’ Patented SmarTest(TM) Technology

Alliance Spine and Pain Centers automate regular behavioral health screening with MHT's patented SmarTest™ platform to address comorbidities between chronic...

Earth Day News: Free CO2 Calculator to Help Hospital Sustainability Managers Track and Reduce Stubborn Supply Chain Emissions by Using Regulated, Reprocessed Single-Use Medical Devices from AMDR Members

GE HealthCare’s MIM Software collaborates with Elekta to help enhance radiation therapy treatments and improve patient outcomes

Collaboration has always been important in the healthcare industry, but in this era of digital health, teamwork across institutions has...

Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society (ONS) Congress in Support of Company’s Expanding Focus on Cancer Supportive Care

Jaguar planning to begin commercial launch of FDA-approved Gelclair® prescription gel for oral mucositis (also called “chemo mouth”) in Q3...

error: Content is protected !!